{"id":"https://openalex.org/W2367076809","doi":null,"title":"Efficacy and safety of combination therapy with saxagliptin and metformin in patients with type 2 diabetes: a meta-analysis","display_name":"Efficacy and safety of combination therapy with saxagliptin and metformin in patients with type 2 diabetes: a meta-analysis","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2367076809","mag":"2367076809"},"language":"en","primary_location":{"id":"mag:2367076809","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=YWBL201205004","pdf_url":null,"source":{"id":"https://openalex.org/S4306557769","display_name":"\u836f\u7269\u4e0d\u826f\u53cd\u5e94\u6742\u5fd7","issn_l":"1008-5734","issn":["1008-5734"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Yaowu buliang fanying zazhi","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2367076809"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059146547","display_name":"Cui Yi-mi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Cui Yi-mi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5059146547"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.875},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8220000267028809},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9070000052452087},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8119999766349792},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.6359999775886536},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7170000076293945},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.39500001072883606},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.5289999842643738},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.3179999887943268},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.9948281645774841},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.915819525718689},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9056035280227661},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6437342166900635},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6293110847473145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6245111227035522},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.55796879529953},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5183935761451721},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4649431109428406},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4271588921546936},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4242554306983948},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4038960933685303},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2242833375930786},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.22314831614494324},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.08402004837989807},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2367076809","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=YWBL201205004","pdf_url":null,"source":{"id":"https://openalex.org/S4306557769","display_name":"\u836f\u7269\u4e0d\u826f\u53cd\u5e94\u6742\u5fd7","issn_l":"1008-5734","issn":["1008-5734"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Yaowu buliang fanying zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2359437798","https://openalex.org/W3030116615","https://openalex.org/W2164282118","https://openalex.org/W3030900679","https://openalex.org/W2803265237","https://openalex.org/W2126065052","https://openalex.org/W2103058881","https://openalex.org/W1963999135","https://openalex.org/W3028647184","https://openalex.org/W2009999012"],"abstract_inverted_index":{"Objective":[0],"To":[1],"evaluate":[2],"the":[3,45,68,127,136,144,154,172,180,199,203,223,228,232,237,261],"efficacy":[4],"and":[5,12,24,26,60,81,99,153,202,231,255,263],"safety":[6,276],"of":[7,33,57,65,116,122,130,166,193,225],"combination":[8,251],"therapy":[9,35,252],"with":[10,16,38,52,70,95,110,253,268],"saxagliptin":[11,34,71,74,137,173,200,229,254],"metformin":[13,256],"in":[14,36,93,104,132,135,143,168,171,179,190,195,222,266],"patients":[15,37,94,267],"type":[17,39,96,269],"2":[18,40,97,270],"diabetes.Methods":[19],"saxagliptinandmetforminwere":[20],"selected":[21],"as":[22,125],"keywords":[23],"PubMed":[25],"EMbase":[27],"were":[28,42,49,91,102,119,124],"searched.All":[29],"randomized":[30],"controlled":[31],"trials(RCTs)":[32],"diabetes":[41,98],"selected.According":[43],"to":[44,214,246,259],"inclusion":[46],"criteria,the":[47],"articles":[48],"selected,evaluated,and":[50],"meta-analyzed":[51],"RevMan":[53],"5.1":[54],"software.The":[55],"levels":[56,134,170,197,265],"glycosylated":[58],"haemoglobin(HbA1c)":[59],"fasting":[61],"plasma":[62],"glucose(FPG),the":[63],"incidence":[64,224],"hypoglycemia":[66,226],"after":[67],"treatment":[69,128,164,191],"+":[72,76,85],"metformin(the":[73,77,86],"group),placebo":[75],"placebo":[78,145,181,233],"control":[79,89,146,157,182,206,234,240],"group)":[80,90],"other":[82],"hypoglycemic":[83],"drugs":[84],"positive":[87,155,204,238],"drug":[88,156,205,239],"compared":[92],"their":[100],"results":[101,121],"presented":[103],"mean":[105],"difference(MD)":[106],"or":[107,236],"relative":[108],"risk(RR)":[109],"95%":[111],"confidence":[112],"interval(CI).Results":[113],"A":[114],"total":[115],"5":[117],"RCTs":[118],"entered.The":[120],"meta-analysis":[123],"follows:":[126],"effect":[129,165,192],"decrease":[131,167,194,260],"HbA1c":[133,262],"group":[138,174,201,207,230,235],"was":[139,175,208,218],"better":[140,176],"than":[141,177],"that":[142,178],"group(MD":[147,158,183],"=-0.59,95%":[148],"CI:-0.87":[149],"to-0.32,P":[150],"=":[151,162,187,216,242,248],"0.00)":[152],"=-0.36,95%":[159],"CI:-0.73":[160],"to-0.54,P":[161],"0.00);the":[163],"FPG":[169,196,264],"=-16.27,95%":[184],"CI:-21.64":[185],"to-10.91,P":[186],"0.00);however,the":[188],"difference":[189,221],"between":[198,227],"not":[209],"statistically":[210],"significant(MD":[211],"=-2.75,95%":[212],"CI:-22.52":[213],"17.01,P":[215],"0.78);there":[217],"no":[219],"significant":[220],"group(RR":[241],"0.55,95%":[243],"CI:":[244],"0.15":[245],"2.09,P":[247],"0.38).Conclusion":[249],"The":[250],"is":[257],"effective":[258],"diabetes.It":[271],"also":[272],"has":[273],"a":[274],"good":[275],"profile.":[277]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2367076809","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
